In addition, PD-L1 protects tumor cells from the cytotoxic effects of type I and type II interferons and cytotoxic T lymphocyte-mediated cell lysis, which is a process that does not require PD-1 signaling in T cells.65 Here, CD274 is linked to neoplasm.